Beryllium dermatitis - 29/08/11
Doi : 10.1016/S0190-9622(03)01555-X
Joshua M Berlin, MD a, James S Taylor, MD a, ⁎ 
, Jessica E Sigel, MD b, Wilma F Bergfeld, MD a, Raed A Dweik, MD c
, Jessica E Sigel, MD b, Wilma F Bergfeld, MD a, Raed A Dweik, MD c a Department of Dermatology, Cleveland Clinic Foundation, Cleveland, Ohio, USA
b Department of Pathology, Cleveland Clinic Foundation, Cleveland, Ohio, USA
c Department of Pulmonary & Critical Care Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
*Reprint requests: Raed A. Dweik, MD, Department of Pulmonary and Critical Care Medicine, A-90, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, USA
Abstract |
Chronic beryllium disease is a granulomatous disorder characterized by a cell-mediated immune response to beryllium. Most reports of chronic beryllium disease discuss pulmonary and noncutaneous immunologic findings. This report of occupational chronic beryllium disease emphasizes cutaneous findings and discusses the potential role of skin exposure in the disease.
Il testo completo di questo articolo è disponibile in PDF.Mappa
 | Funding sources: None. Conflict of interest: None identified. |
© 2003
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 49 - N° 5
P. 939-941 - novembre 2003 Ritorno al numero
Articolo precedente
- Topical methotrexate for lymphomatoid papulosis
- Jane S Bergstrom, Christine Jaworsky
- Primary mucinous carcinoma in a 54-year-old man
- Christine E Cabell, Klaus F Helm, Peter J Sakol, Elizabeth M Billingsley
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?